Nutritional Growth Solutions creates nutritional supplements that are scientifically formulated by paediatric doctors, patented, and clinically proven to support growth development in children.

Their protein-shake powder was developed by physicians and nutrition experts to support and enhance diet to promote height. The formula, based on food components that are important for proper growth, has been shown in a clinical study to boost kids’ (3–9 years) height and weight, without a change in BMI percentiles.

Nutritional Growth Solutions distributes its formula globally, using diverse channels to market the shake powder under different brand names.


  • David Fenlon, Non Executive Chairman

    Fenlon has over 30 years’ experience in retail and consumer goods across Europe, Australasia and North America. Until very recently he was the managing director and CEO of leading beauty and wellness business, BWX Limited, and was previously managing director – Australia and NZ for Blackmores Limited. 

    In addition, Fenlon is currently a non-executive director of the Quest for Life Foundation, an Australian not-for-profit organisation dedicated to supporting people through personal traumas. 

    read more
  • Liron Fendell, CEO and Managing Director

    Ms Fendell has experience in nutrition, emerging technology and global child health. Ms Fendell was previously a corporate lawyer in one of Tel Aviv’s law firms, representing bio tech start-ups as well as pharmaceutical companies, and gaining experience in structuring, negotiating and executing business transactions. Since 2012, Ms Fendell has served as a board member of CPC – Children Playing Chess, a non-profit organization. Struggling with her own children’s nutrition and growth, Ms Fendell joined the Company on its creation in 2014 to work with the founding doctors at Schneider in order to convert the clinical knowledge and data into tangible products and commercial business.

    read more
  • Dr Kinneret Livnat, Director

    Kinneret has over 25 years of experience in senior leadership positions in the biopharmaceutical industry, including vast experience in different aspects of drug discovery and development, deal making and fund-raising.

    Kinneret is a Director and Chairperson of the board of directors at a variety of biotech companies, and held director or chairperson position in a number of companies and organizations including Compugen Ltd.  KAHR Medical, DreaMed Diabetes, Biomica, Nutritional Growth Solutions (NGS. AU),  Hadasit, Ramot, Tel Aviv University’s tech transfer arm and FutuRx and its portfolio companies.

    Prior to joining FutuRx, Kinneret served as the CEO of BioLineRx, a biopharmaceutical company focused on oncology, where she previously served as General Manager of BioLine Innovations Jerusalem, a biotech incubator wholly-owned by BioLineRx and Vice President of Drug Development at BioLineRx. Before BioLineRx, Kinneret held the position of Vice President of Biology of Compugen Ltd., cancer immunotherapy company and a leader in predictive target discovery.

    read more
  • Prof. Ranaan Shamir, Director

    Prof Shamir is Chairman of the Institute of Gastroenterology, Nutrition and Liver Diseases at Schneider. In the early 90s, he was a fellow at the Division of Pediatric Gastroenterology and Nutrition at The Children’s Hospital of Philadelphia. Prof Shamir has published approximately 400 original papers, reviews and comments, book chapters and guidelines. His current research areas include paediatric nutrition, nutrition and growth, celiac disease, inflammatory bowel disease and childhood hyperlipidemia. Prof Shamir is a co-founder of the Company

    read more
  • Dr Anton Uvarov, Director

    Dr Anton Uvarov has significant experience as an equity analyst, both domestically and internationally, and is particularly interested in early-stage startups. Prior to his move to Australia, Dr Uvarov was senior associate at Citigroup Global Markets where he spent two years as a member of New York based healthcare team. In 2013, Dr Uvarov joined the boards of Actinogen Medical and Imugene. Dr Uvarov has a PhD from University of Manitoba, Canada and an MBA from University of Calgary, Canada

    read more
  • Mr Amir Zaidman, Non Executive Director

    Mr Zaidman has 20 years of experience in business development and venture capital investments. Since 2014, Mr Zaidman has served as the vice president of business development of “The Kitchen Hub” – the first FoodTech focused seed investor and technology incubator in Israel. In this capacity he provides business development and marketing support to portfolio companies and is also in charge of The Kitchen Hub’s new investments, and has led the investment process in 18 portfolio companies to date. Mr Zaidman serves on the board of directors of numerous private FoodTech companies. Mr Zaidman is a executive in the FoodTech community in Israel. He created and manages the Israel FoodTech Innovation Linkedln group as well as the Israel’s FoodTech Community MeetUp group. He is also Chair of Risk Committee of the Company.

    read more